论文信息 - Survival update in randomized phase II trial of S-1/cisplatin (SP) or docetaxel/cisplatin (DP) with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer (NSCLC)-TORG1018. - 字舞流文

Survival update in randomized phase II trial of S-1/cisplatin (SP) or docetaxel/cisplatin (DP) with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer (NSCLC)-TORG1018.

Y. Hosomi | Y. Takiguchi | N. Nogami | T. Shimokawa | S. Igawa | Takashi Kasai | K. Kubota | Haruhiro Saito | T. Kato | Takeharu Yamanaka | Hiroaki Okamoto | K. Yamada | Hisashi Tanaka | Kazuma Kishi | Yusuke Nakamura